Sadhana Nitro Chem Limited (BOM:506642)
5.95
-0.21 (-3.41%)
At close: Jan 21, 2026
Sadhana Nitro Chem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 1,419 | 1,900 | 1,900 | 1,433 | 1,317 | 1,031 | Upgrade |
Other Revenue | -0 | -0 | -0 | - | - | - | Upgrade |
| 1,419 | 1,900 | 1,900 | 1,433 | 1,317 | 1,031 | Upgrade | |
Revenue Growth (YoY) | -24.38% | - | 32.59% | 8.82% | 27.82% | -2.84% | Upgrade |
Cost of Revenue | 621.43 | 629.73 | 852.72 | 709.19 | 745.67 | 423.15 | Upgrade |
Gross Profit | 797.24 | 1,271 | 1,048 | 724.16 | 571.55 | 607.35 | Upgrade |
Selling, General & Admin | 210.58 | 231.98 | 225.35 | 173.59 | 161.44 | 156.81 | Upgrade |
Other Operating Expenses | 247.81 | 370.51 | 410.39 | 319.11 | 263.6 | 174.07 | Upgrade |
Operating Expenses | 613.81 | 754.31 | 784.85 | 568.75 | 486.06 | 392.85 | Upgrade |
Operating Income | 183.43 | 516.43 | 262.9 | 155.41 | 85.49 | 214.49 | Upgrade |
Interest Expense | -172.19 | -169.29 | -123.86 | -90.32 | -24.93 | -3.46 | Upgrade |
Interest & Investment Income | 11.97 | 11.97 | 7.56 | 7.79 | 15.71 | 4.41 | Upgrade |
Currency Exchange Gain (Loss) | 6.24 | 6.24 | -0.25 | -17.14 | 2.06 | -9.43 | Upgrade |
Other Non Operating Income (Expenses) | -224.72 | -250.22 | -39.73 | -1.55 | -11.6 | -23.41 | Upgrade |
EBT Excluding Unusual Items | -195.27 | 115.13 | 106.62 | 54.18 | 66.72 | 182.61 | Upgrade |
Merger & Restructuring Charges | - | - | -0.31 | - | -0.32 | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | 0.51 | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 3.99 | Upgrade |
Other Unusual Items | - | - | 21.46 | 2.33 | 22.71 | - | Upgrade |
Pretax Income | -195.27 | 115.13 | 128.28 | 56.51 | 89.11 | 186.6 | Upgrade |
Income Tax Expense | 14.56 | 39.56 | 87.46 | 24.73 | 26.86 | 27.35 | Upgrade |
Net Income | -209.82 | 75.58 | 40.82 | 31.78 | 62.25 | 159.25 | Upgrade |
Net Income to Common | -209.82 | 75.58 | 40.82 | 31.78 | 62.25 | 159.25 | Upgrade |
Net Income Growth | - | 85.16% | 28.43% | -48.94% | -60.91% | 8.69% | Upgrade |
Shares Outstanding (Basic) | 338 | 283 | 247 | 247 | 239 | 239 | Upgrade |
Shares Outstanding (Diluted) | 338 | 283 | 247 | 247 | 239 | 239 | Upgrade |
Shares Change (YoY) | 42.32% | 14.70% | - | 3.33% | - | - | Upgrade |
EPS (Basic) | -0.62 | 0.27 | 0.17 | 0.13 | 0.26 | 0.67 | Upgrade |
EPS (Diluted) | -0.62 | 0.27 | 0.17 | 0.13 | 0.26 | 0.67 | Upgrade |
EPS Growth | - | 61.42% | 28.43% | -50.59% | -60.91% | 8.69% | Upgrade |
Free Cash Flow | -393.2 | -394.6 | -681.62 | -861.17 | -457.73 | -235.56 | Upgrade |
Free Cash Flow Per Share | -1.16 | -1.39 | -2.76 | -3.49 | -1.91 | -0.98 | Upgrade |
Dividend Per Share | - | - | 0.150 | 0.123 | 0.123 | - | Upgrade |
Dividend Growth | - | - | 22.25% | - | - | - | Upgrade |
Gross Margin | 56.20% | 66.86% | 55.13% | 50.52% | 43.39% | 58.94% | Upgrade |
Operating Margin | 12.93% | 27.17% | 13.83% | 10.84% | 6.49% | 20.81% | Upgrade |
Profit Margin | -14.79% | 3.98% | 2.15% | 2.22% | 4.73% | 15.45% | Upgrade |
Free Cash Flow Margin | -27.72% | -20.76% | -35.87% | -60.08% | -34.75% | -22.86% | Upgrade |
EBITDA | 265.56 | 594.96 | 337.46 | 205.5 | 132.28 | 263.19 | Upgrade |
EBITDA Margin | 18.72% | 31.31% | 17.76% | 14.34% | 10.04% | 25.54% | Upgrade |
D&A For EBITDA | 82.13 | 78.53 | 74.56 | 50.09 | 46.79 | 48.69 | Upgrade |
EBIT | 183.43 | 516.43 | 262.9 | 155.41 | 85.49 | 214.49 | Upgrade |
EBIT Margin | 12.93% | 27.17% | 13.83% | 10.84% | 6.49% | 20.81% | Upgrade |
Effective Tax Rate | - | 34.36% | 68.18% | 43.76% | 30.14% | 14.66% | Upgrade |
Revenue as Reported | 1,484 | 1,940 | 1,940 | 1,451 | 1,367 | 1,080 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.